KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Equity Average (2016 - 2026)

Quest Diagnostics' Equity Average history spans 18 years, with the latest figure at $7.4 billion for Q1 2026.

  • On a quarterly basis, Equity Average rose 7.7% to $7.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $7.4 billion, a 7.7% increase, with the full-year FY2025 number at $7.0 billion, up 6.29% from a year prior.
  • Equity Average hit $7.4 billion in Q1 2026 for Quest Diagnostics, up from $7.2 billion in the prior quarter.
  • Over the last five years, Equity Average for DGX hit a ceiling of $7.4 billion in Q1 2026 and a floor of $6.0 billion in Q1 2023.
  • Historically, Equity Average has averaged $6.6 billion across 5 years, with a median of $6.4 billion in 2022.
  • Biggest five-year swings in Equity Average: fell 6.82% in 2023 and later grew 8.4% in 2025.
  • Tracing DGX's Equity Average over 5 years: stood at $6.1 billion in 2022, then rose by 4.94% to $6.4 billion in 2023, then rose by 6.63% to $6.8 billion in 2024, then grew by 5.67% to $7.2 billion in 2025, then grew by 2.83% to $7.4 billion in 2026.
  • Business Quant data shows Equity Average for DGX at $7.4 billion in Q1 2026, $7.2 billion in Q4 2025, and $7.3 billion in Q3 2025.